{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:42:34Z","timestamp":1776408154760,"version":"3.51.2"},"reference-count":20,"publisher":"BMJ","issue":"Suppl 3","license":[{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"unspecified","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/T022132\/1"],"award-info":[{"award-number":["MR\/T022132\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2022,12,10]]},"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:p>Poor-quality medicines are a major threat to healthcare provision in low-income countries. The problem exacerbates disease vulnerabilities of already disadvantaged populations including children, women, and the elderly. However, while the higher-level structural drivers of this problem are well established, little is known about decision-making lower down pharmaceutical supply chains, and whether this might produce vulnerabilities for medicine quality. We conducted a mixed-methods study to explore retailer\u2013supplier interactions and decision-making dynamics for antimalarial medicines in three regions of Tanzania: Tabora, Dodoma and Mbeya. A survey questionnaire was administered to 118 small scale-and mid-range retailers in urban and rural districts of the regions. We then conducted 12 in-depth interviews with staff and owners of medicine outlets in 2 districts of Tabora region to explore further the decision-making dynamics. Results show that private-sector retailers are driven first and foremost by business and economic practicalities when choosing a medicine supplier, prioritising low purchase price, free delivery, and availability of credit. Many also rely on suppliers with whom they have personal connections, developed either within or outside the business context. Medicine quality comes far lower down the list of priorities. These findings are perhaps not surprising in a context where businesses serving low-income customers are operating on very small margins. However, when price and personal connection eclipse any other considerations, there is a risk that poor-quality medicines may find their way into supply chains, especially in countries where regulatory capacity is limited, and pharmaceutical supply chains are complex and opaque.<\/jats:p>","DOI":"10.1136\/bmjgh-2022-010821","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:10:12Z","timestamp":1694391012000},"page":"e010821","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Antimalarial procurement in private-sector pharmaceutical outlets: decision-making complexities and implications for medicine quality in Tanzania"],"prefix":"10.1136","volume":"6","author":[{"given":"Gerry","family":"Mshana","sequence":"first","affiliation":[{"name":"National Institute for Medical Research, Mwanza Research Centre, Mwanza, Tanzania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tubeti","family":"Mayebe","sequence":"additional","affiliation":[{"name":"National Institute for Medical Research, Mwanza Research Centre, Mwanza, Tanzania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Balira","sequence":"additional","affiliation":[{"name":"National Institute for Medical Research, Mwanza Research Centre, Mwanza, Tanzania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0301-7057","authenticated-orcid":false,"given":"Heather","family":"Hamill","sequence":"additional","affiliation":[{"name":"Department of Sociology, Oxford University, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Hampshire","sequence":"additional","affiliation":[{"name":"Department of Anthropology, Durham University, Durham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,9,10]]},"reference":[{"key":"2025073014062683000_6.Suppl_3.e010821.1","unstructured":"WHO . Study on the public health & socioeconomic impact of SF medical products. Geneva: World Health Organisation, 2017."},{"key":"2025073014062683000_6.Suppl_3.e010821.2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2020-003043","article-title":"Monitoring, reporting and regulating medicine quality: tensions between theory and practice in Tanzania","volume":"6","author":"Hamill","year":"2021","journal-title":"BMJ Glob Health"},{"key":"2025073014062683000_6.Suppl_3.e010821.3","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-13-209"},{"key":"2025073014062683000_6.Suppl_3.e010821.4","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-016-1096-x","article-title":"Fake anti-malarials: start with the facts","volume":"15","author":"Kaur","year":"2016","journal-title":"Malar J"},{"key":"2025073014062683000_6.Suppl_3.e010821.5","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-13-139"},{"key":"2025073014062683000_6.Suppl_3.e010821.6","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czm033"},{"key":"2025073014062683000_6.Suppl_3.e010821.7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003403","article-title":"A nationwide survey of the quality of antimalarials in retail outlets in Tanzania","volume":"3","author":"Kaur","year":"2008","journal-title":"PLoS One"},{"key":"2025073014062683000_6.Suppl_3.e010821.8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248057","article-title":"In vitro growth competition experiments that suggest consequences of the substandard artemisinin epidemic that may be accelerating drug resistance in P Falciparum malaria","volume":"16","author":"Hassett","year":"2021","journal-title":"PLOS ONE"},{"key":"2025073014062683000_6.Suppl_3.e010821.9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40360-021-00514-w","article-title":"Quality of selected anti-retroviral medicines: Tanzania mainland market as a case study","volume":"22","author":"Mziray","year":"2021","journal-title":"BMC Pharmacol Toxicol"},{"key":"2025073014062683000_6.Suppl_3.e010821.10","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.14-0343"},{"key":"2025073014062683000_6.Suppl_3.e010821.11","doi-asserted-by":"crossref","DOI":"10.12688\/wellcomeopenres.15236.1","article-title":"Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania","volume":"4","author":"Pisani","year":"2019","journal-title":"Wellcome Open Res"},{"key":"2025073014062683000_6.Suppl_3.e010821.12","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/jeea\/jvab053","article-title":"Can good products drive out bad? A randomized intervention in the antimalarial medicine market in Uganda","volume":"20","author":"Bj\u00f6rkman Nyqvist","year":"2022","journal-title":"J Eur Econ Assoc"},{"key":"2025073014062683000_6.Suppl_3.e010821.13","unstructured":"Ministry of Health, Community Development, Gender, Elderly and Children (MoHCDGEC) [Tanzania Mainland], Ministry of Health (MoH) [Zanzibar], National Bureau of Statistics (NBS), Office of the Chief Government Statistician (OCGS), and ICF . In: Tanzania malaria indicator survey 2017. Dar es Salaam, Tanzania, and Rockville, Maryland, USA: MoHCDGEC, MoH, NBS, OCGS, and ICF, Available: https:\/\/dhsprogram.com\/pubs\/pdf\/MIS31\/MIS31.pdf"},{"key":"2025073014062683000_6.Suppl_3.e010821.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2018.01.008"},{"key":"2025073014062683000_6.Suppl_3.e010821.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhealeco.2011.08.006"},{"key":"2025073014062683000_6.Suppl_3.e010821.16","doi-asserted-by":"publisher","DOI":"10.1111\/jems.12114"},{"key":"2025073014062683000_6.Suppl_3.e010821.17","doi-asserted-by":"publisher","DOI":"10.1080\/11287462.2022.2103899"},{"key":"2025073014062683000_6.Suppl_3.e010821.18","doi-asserted-by":"publisher","DOI":"10.2174\/1574886311308010007"},{"key":"2025073014062683000_6.Suppl_3.e010821.19","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/14787210.2016.1187560","article-title":"A link between poor quality antimalarials and malaria drug resistance?","volume":"14","author":"Newton","year":"2016","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2025073014062683000_6.Suppl_3.e010821.20","doi-asserted-by":"crossref","unstructured":"Ackland GJ , Chattoe-Brown E , Hamill H , et al . Role of trust in self-organizing pharmaceutical supply chain model with variable good quality and imperfect information. JASSS 2019;22. doi:10.18564\/jasss.3984","DOI":"10.18564\/jasss.3984"}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2022-010821","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T21:06:34Z","timestamp":1753909594000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2022-010821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":20,"journal-issue":{"issue":"Suppl 3","published-online":{"date-parts":[[2023,9,10]]},"published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1136\/bmjgh-2022-010821"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2022-010821","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}